Psychedelics and Healing

MDMA shows promising results, with about two-thirds of trauma patients experiencing significant relief after just one or two sessions. In contrast, psilocybin offers hope for depression, with open-label studies indicating a 50-66% improvement rate, although blinded trials suggest around a third may benefit. Both treatments highlight a potential shift in how we approach mental health care.